| DC Field | Value | Language |
|---|
| dc.contributor.author | Darciuc, Radu | |
| dc.contributor.author | Ivanov, Daniela | |
| dc.contributor.author | Hakan, Eraslan | |
| dc.contributor.author | Erdem, Diker | |
| dc.date.accessioned | 2020-06-30T15:28:10Z | |
| dc.date.available | 2020-06-30T15:28:10Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | DARCIUC, Radu, IVANOV, Daniela, HAKAN, Eraslan, ERDEM, Diker. Treatment for ventricular tachycardia in the absence of structural heart disease. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 16-17 | en_US |
| dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/10784 | |
| dc.description | Medpark International Hospital, Cardiology and Interventional Cardiology Department,
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova,
TOBB University of Economics and Technology Hospital, Cardiology Department, Ankara,
Turkey | en_US |
| dc.description.abstract | Background. According to the recent data in up to 10% of the patients with ventricular
tachycardia (VT) there is an absence of structural heart disease. Several types of VT could be
present in such patients: right ventricular outflow tract (RVO T) VT, caticholaminergic
polymorphic VT, idiopathic left VT, Brugada syndrome, long QT syndrome. According to the
VT type the management can be pharmacological therapy, radio-frequency ablation,
implantation of cardioverter defibrillator or a combination of them. The decision about the
management is based on the type of VT, data obtained from echocardiography, magnetic
resonance imaging (MRI) and electrophysiological study (EPS). | |
| dc.language.iso | en | en_US |
| dc.publisher | MedEspera | |
| dc.subject | ventricular tachycardia | en_US |
| dc.subject | structural disease | en_US |
| dc.title | Treatment for ventricular tachycardia in the absence of structural heart disease | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | MedEspera 2018
|
